Hannah van der Stok

Hannah van der Stok

Auto-generated profile, based on publicly available information

Hannah van der Stok

Molecular Cell Biology and Immunology, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands; MS Center Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2021 in eLife
Verified
Journal Article
Open access
GBGerrit Cornelis Beekhof
Gerrit Cornelis Beekhof
COCatarina Osorio
Catarina Osorio
JWJoshua J White
Joshua J White
SZScott van Zoomeren
Scott van Zoomeren
HSHannah van der Stok
Hannah van der Stok
MSMartijn Schonewille
Martijn Schonewille
Distinct populations of Purkinje cells (PCs) with unique molecular and connectivity features are at the core of the modular organization of the cerebellum. Previously, we showed that firing activity of PCs differs between ZebrinII-positive and ZebrinII-negative cerebellar modules (Zhou et al., 2014; Wu et al., 2019). Here, we investigate the timing and extent of PC differentiation during development in mice. We found that several features of PCs, including activity levels, dendritic arborization, axonal shape and climbing fiber input, develop differentially between nodular and anterior PC populations. Although all PCs show a particularly rapid development in the second postnatal week, anterior PCs typically have a prolonged physiological and dendritic maturation. In line herewith, younger mice exhibit attenuated anterior-dependent eyeblink conditioning, but faster nodular-dependent compensatory eye movement adaptation. Our results indicate that specific cerebellar regions have unique developmental timelines which match with their related, specific forms of cerebellum-dependent behaviors.

19 July 2025 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Open access
HSH. van der Stok
H. van der Stok
LCL. Coenen
L. Coenen
MWM. Weil
M. Weil
JMJ.E. Mollon
J.E. Mollon
CKC. Klein
C. Klein
MRMerel Rijnsburger
Merel Rijnsburger
Grey matter (GM) lesions and atrophy in multiple sclerosis (MS) are strongly correlated to disease progression and cognitive decline, but molecular mechanisms underlying GM lesion formation remain unclear. Various studies have used a proteomics approach to study changes in cerebrospinal fluid or blood. However, very few studies have been performed in tissue and especially GM lesions are understudied, despite the importance of these lesions in disease progression. For this explorative study, we applied Olink proteomics to unravel differentially expressed proteins in the GM of MS patients (n = 9) compared to controls (n = 10). First, we evaluated which of the 184 proteins in a neurology and inflammation panel could accurately distinguish MS from control by applying a classifier based on unbiased variable selection. The classifier consisted of five proteins: HGF, PVR, NEP, EFNA4 and LAP.TGF.beta1. These were all differentially expressed in GMLs of MS patients (FDR < 0.1), amongst twelve others. Additionally, we studied proteomic changes between MS cases with different GM lesion loads and identified IL-20, CD5 and GZMA to distinguish large from small lesions. Eight other proteins were nominally differentially expressed based on lesion load. Future studies should explore the potential of targeting these proteins to hamper grey matter pathology.